You are here

cancer

Bristol Myers pays SystImmune $800M and adds to pharma’s ‘ADC’ deal spree

BioPharma Dive

Tue, 12/12/23 - 09:58 am

Bristol Myers Squibb

antibody-drug conjugate

Oncology drugmakers seek the sweet spot between efficacy and tolerability

Pharma Voice

Mon, 12/11/23 - 10:16 am

drug development

Moderna, Merck begin late-stage study for mRNA cancer therapy

Reuters

Mon, 12/11/23 - 10:00 am

Moderna Therapeutics

clinical trials

Dupixent for cancer? Researchers test blockbuster med as an immunotherapy-booster

Fierce Biotech

Thu, 12/7/23 - 11:13 pm

CRISPR eyes autoimmune disease in revamp of cell therapy plans

BioPharma Dive

Tue, 12/5/23 - 11:38 am

CRISPR Therapeutics

autoimmune disease

AstraZeneca, AI biologics firm Absci tie up on cancer drug

Reuters

Sun, 12/3/23 - 09:31 pm

artificial intelligence

Merck turns to Acclinate to increase African American participation in cancer trials

Fierce Biotech

Thu, 11/30/23 - 09:52 am

clinical trials

clinical trial diversity

BeiGene Inks Potential $1.3B Deal with Ensem for Early-Stage CDK2 Inhibitor

BioSpace

Tue, 11/21/23 - 11:54 am

Gilead Oncology’s brand refresh takes back the possibilities cancer steals

Medical Marketing and Media

Mon, 11/20/23 - 09:36 pm

Gilead Oncology

FDA's oncology office uses advisory committee to spotlight timely accelerated approval confirmation

Fierce Pharma

Wed, 11/15/23 - 11:20 am

accelerated approvals

Acrotech Biopharma

Nouscom raises $72m in Series C financing round to develop cancer vaccines

Clinical Trials Arena

Tue, 11/14/23 - 09:54 pm

cancer vaccines

Cidara’s J&J-partnered immunotherapy could target flu and cancer

Pharma Voice

Thu, 10/26/23 - 10:35 am

drug-Fc conjugates

Moderna, Caris Life Team Up to Advance mRNA-Based Oncology Therapeutics

Marketwatch

Wed, 10/25/23 - 09:55 am

Moderna Therapeutics

Caris Life Sciences

ESMO: AstraZeneca aims for ‘2.0’ cancer pipeline, shares bispecific data

Fierce Biotech

Tue, 10/24/23 - 07:52 pm

Merck discontinues some cancer drug development with China's Sichuan Kelun

Reuters

Tue, 10/24/23 - 10:00 am

Sichuan Kelun Pharmaceutical

Charles River offers clients new database for pediatric oncology research

Biopharma Reporter

Tue, 10/24/23 - 09:40 am

Charles River Labs

Myriad touts the role of genetic testing in identifying cancer risks

Medical Marketing and Media

Mon, 10/23/23 - 05:16 pm

Myriad Genetics

genetic testing

ESMO: Rain in Spain doesn’t dampen spirits of 33,000 oncologists

Fierce Pharma

Mon, 10/23/23 - 09:17 am

Relay Therapeutics Pauses Lirafugratinib Rare Cancer Plans Due to IRA

BioSpace

Fri, 10/13/23 - 11:57 am

Relay Therapeutics

Inflation Reduction Act

BioNTech Inks Potential $1B Deal with MediLink for Cancer-Focused ADCs

BioSpace

Fri, 10/13/23 - 11:56 am

antibody-drug conjugate

Pages